STOK filings
Corporate insider profile
Jonathan Allan Filing Activity
Latest reported as GENERAL COUNSEL & CORP SEC of Stoke Therapeutics, Inc. (STOK).
- Purchase filings
- 0
- Reported companies
- 1
- Net open-market value
- -$43,637.15
- Latest transaction
- Jun 16, 2026
Affiliated corporations
Reported company relationships
Transaction history
